Clinical Trial
Offered by: Nemours Children's
Locations: Delaware Valley, Jacksonville, Fla., Orlando and Pensacola, Fla.
Trial Name
A Phase II Randomized Trial of Lenalidomide (NSC # 703813, IND # 70116) in Pediatric Patients With Recurrent, Refractory, or Progressive Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas
What is the trial about?
To find out what effects low and high doses of lenalidomide have on children, adolescents, and young adults with recurrent/refractory/progressive JPA or OPG.
Who can participate?
Children with juvenile pilocytic astrocytomas (JPA) or an optic pathway glioma (OPG).
What is involved?
Length of study is 24 months. Standard cancer care.
Contact Nemours Children's Clinical Trials
Trial Name: A Phase II Randomized Trial of Lenalidomide (NSC # 703813, IND # 70116) in Pediatric Patients With Recurrent, Refractory, or Progressive Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas
ACNS#: 1022
(800) 354-5690 Email UsIs a Clinical Trial Right for Your Child?
Learn more about clinical trials and get answers to questions you might have.
Go to FAQs View All Clinical Trials
Nemours has a number of service regions. Selecting your region will help us show you the right contact information and the most relevant content for you.